Message from the Chair

The Mount Sinai Hospital, one of the country's oldest and largest voluntary teaching hospitals, is internationally acclaimed for its clinical care, education, and scientific research excellence. Established in 1914 by Dr. Charles Elsberg, the Neurosurgery program at Mount Sinai proudly continues this tradition of excellence. Today, the Mount Sinai Health System includes the Icahn School of Medicine at Mount Sinai and eight hospital campuses in the New York metropolitan area, as well as a large, regional ambulatory footprint.

Our neurosurgery faculty specializes in the surgical treatment of adults and children with diseases and disorders related to the brain, spinal cord, and peripheral nerve. We are internationally renowned for our expertise in skull base surgery, cerebrovascular disease, neurosurgical oncology, skull based tumors including pituitary and acoustic tumors, neuromodulation by deep brain stimulation, complex spinal reconstruction, epilepsy, radiosurgery, and neuroendoscopy.

We offer a residency program designed to provide well-rounded training in all aspects of clinical neurosurgery. We seek to prepare each of our residents for an outstanding career as a surgeon and research investigator. Our program offers a full year of protected research experience, as well as rotations through neurology, neuropathology, pediatric neurosurgery, endovascular neurosurgery, neuroradiology, and radiosurgery.

The interaction between the Department’s research and clinical teams enables us to rapidly translate research findings into new therapies and better approaches to patient care. Supported by National Institutes of Health funding, private foundation grants, and philanthropy, our faculty publishes findings from research utilizing stem cell research, immunotherapy, and neuromodulation by deep brain stimulation. We have also published studies on minimally invasive skull base surgery, pituitary and neuroendocrine disorders, 5-ALA fluorescence-guided surgery, cancer nanotechnology, neuro-endoscopy, axonal regeneration, glioma invasion, cancer stem cells, stroke, subarachnoid hemorrhage, intracranial aneurysms, carotid stenting, cerebral blood flow, and metabolism.

As we look to the future, we remain committed to our mission to deliver world class, compassionate care to our patients today, and further the field of neurosurgery to help our patients tomorrow.

Sincerely yours,

Joshua B. Bederson, MD, FACS
Professor and Chair
Department of Neurosurgery